A leading British medical journal is asking drugmaker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.Tuesday, 13 November, 2012, 2:56am
Simcere founder aims to lift industry's image
In April, Ren Jinsheng realised a dream - listing on the New York Stock Exchange the pharmaceutical company he founded in 1995 with a meagre 50,000 yuan.
Simcere Pharmaceutical Group is now the biggest mainland drug firm listed in the United States with a market capitalisation of about US$900 million.24 Sep 2007 - 12:00am
United States pharmaceutical and health-care firm Wyeth said if the central government failed to speed up the regulatory procedures for approving new drugs, the company would consider shifting its Asian base to India.26 Mar 2007 - 12:00am
Pharmaceutical firms say that unless patent laws change, HK may lose out forever
Foreign pharmaceutical firms are urging the Hong Kong government to bring drug patent protection in line with international standards, alleging that its poor track record has essentially eliminated foreign investment in the sector.21 Jun 2004 - 12:00am
Anglo-Swedish pharmaceutical giant AstraZeneca has invested US$100 million in a new drug manufacturing facility near Shanghai and expects further investment as China becomes more committed to protecting intellectual property rights.1 May 2001 - 12:00am
United States pharmaceutical firm Schering-Plough has announced a US$465 million investment in Singapore in a move dovetailing with a government drive to develop the life-science sector.
Minister for Trade and Industry George Yeo said the city-state was committed to making life sciences 'an important pillar of Singapore's economy in the coming decades'.9 Dec 2000 - 12:00am
Foreign-invested joint ventures have captured one third of the mainland's drugs market and the proportion is rising, with domestic firms unable to match them in developing and marketing new drugs.
Domestic firms are also handicapped by price controls not applied to foreign firms.1 Nov 1999 - 12:00am
China Pharmaceutical Enterprise and Investment Corp is to invest HK$47.25 million in two pharmaceutical plants owned by its parent, Shijiazhuang Pharmaceutical Group. The consideration for the investment will be financed internally.12 May 1997 - 12:00am
China's new rules on branding pharmaceutical products will affect foreign manufacturers badly, a consultant says.
The Ministry of Health is drafting legislation which will further restrict the branding of pharmaceutical products. Its drug administration bureau will submit recommendations this year.26 Sep 1996 - 12:00am